Key takeaways
Fairness and Equity regarding Extension of Time Limits
✓
Defendants have not consented to the extension of the time limits. However, the requested extension is justified on the grounds of fairness and equity (see the 5th recital in the Preamble to the Rules of Procedure), since the previous time limit was, with the consent of the Claimant, extended to a similar extent in favour of the Defendants.
Division
LD Düsseldorf
UPC number
UPC_CFI_499/2023
Type of proceedings
Patent infringement action and Counterclaim for revocation
Parties
Claimant: DexCom, Inc.
Defendants:
- Abbott Laboratories
- Abbott Diabetes Care Inc.
- Abbott GmbH
- Abbott Diagnostics GmbH
- Abbott Laboratories GmbH
- Abbott Logistics B.V
- Abbott France (S.A.S.)
- Abbott s.r.l
- Abbott Gesellschaft m.b.H
- Abbott B.V.
- Abbott (S.A./N.V.)
- Abbott Scandinavia Aktiebolag
- Abbott Oy
Patent(s)
EP 4 026 488
Body of legislation / Rules
R. 9.3 (a) RoP
